Colesevelam Hydrochloride

盐酸考来维仑

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameColesevelam Hydrochloride
Drug Alias Name考来维仑盐酸盐LodaliscolesevelamcolesevelamumColestagel +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid binding protein modulators
TargetsBile acid binding protein
Therapy Area/IndicationsHeterozygous familial hypercholesterolemiaChemically-Induced DisordersDiarrhea +[12] 
Global Approved IndicationsHypercholesterolemiaHyperlipidemiasDiabetes Mellitus, Type 2 +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2000/05/26
Country/TerritoryUnited StatesNetherlandsMexico +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoUniversity Of Rhode IslandGenzyme Europe Bv +[6] 
Inactive CompaniesCosette Pharmaceuticals IncHealthpartners InstituteSeattle Institute For Biomedical And Clinical Research +[6] 
Active IndicationsChemically-Induced DisordersHypercholesterolemiaHyperlipidemias +[6] 
Inactive IndicationsHeterozygous familial hypercholesterolemiaDiarrheaPrediabetic State +[6] 

Other Information

ATC CodeC10AC04
Related LinksWikipediaDrugBankKEGG